LLY vs MRK
Eli Lilly and Company · Merck & Company Inc
Relative return (rebased to 100)
Key stats
| Metric | LLY | MRK |
|---|---|---|
| Price | $1,417.54 | $149.52 |
| Market Cap | $1.33T | $368.89B |
| P/E | 64.61 | 20.21 |
| P/B | 33.11 | 8.80 |
| P/S | 20.46 | 5.67 |
| ROE | 51.3% | 43.5% |
| Net Margin | 31.7% | 28.1% |
| Gross Margin | — | — |
| Revenue Growth | 44.7% | 1.3% |
| Dividend Yield | 0.44% | 2.19% |
| EPS | $21.94 | $7.40 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.